Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TLSI

TriSalus Life Sciences (TLSI)

TriSalus Life Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TLSI
DateTimeSourceHeadlineSymbolCompany
05/24/20246:05AMBusiness WireTriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to WarrantsNASDAQ:TLSITriSalus Life Sciences Inc
05/15/20248:00AMBusiness WireTriSalus Reports Q1 2024 Financial Results and Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
05/07/20247:00AMBusiness WireTriSalus Life Sciences Appoints Liselotte Hyveled to its Board of DirectorsNASDAQ:TLSITriSalus Life Sciences Inc
05/06/20244:58PMBusiness WireTriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference CallNASDAQ:TLSITriSalus Life Sciences Inc
04/30/20244:35PMBusiness WireTriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth InitiativesNASDAQ:TLSITriSalus Life Sciences Inc
04/01/20248:00AMBusiness WireTriSalus Reports Q4 and Full Year 2023 Financial Results and Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
03/26/20248:00AMBusiness WireTriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific MeetingNASDAQ:TLSITriSalus Life Sciences Inc
03/21/20248:00AMBusiness WireTriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific MeetingNASDAQ:TLSITriSalus Life Sciences Inc
03/11/20245:15PMBusiness WireTriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial ResultsNASDAQ:TLSITriSalus Life Sciences Inc
03/07/20247:00AMBusiness WireTriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for “Nelitolimod” as the Nonproprietary Drug Name for SD-101NASDAQ:TLSITriSalus Life Sciences Inc
02/29/20247:00AMBusiness WireTriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver TumorsNASDAQ:TLSITriSalus Life Sciences Inc
02/14/20246:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
02/14/20246:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
02/14/20246:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
02/14/20246:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
02/14/20246:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
01/25/20245:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
01/25/20245:23PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
01/25/20245:21PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
01/25/20245:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLSITriSalus Life Sciences Inc
01/05/20244:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLSITriSalus Life Sciences Inc
12/27/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TLSITriSalus Life Sciences Inc
12/27/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TLSITriSalus Life Sciences Inc
12/26/20235:28PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
12/26/20235:27PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
11/14/20238:00AMBusiness WireTriSalus Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
11/07/20234:05PMBusiness WireTriSalus Life Sciences to Host Third Quarter 2023 Financial Results Conference CallNASDAQ:TLSITriSalus Life Sciences Inc
11/04/20232:25PMBusiness WireLate-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas IndicationsNASDAQ:TLSITriSalus Life Sciences Inc
11/03/202312:00PMBusiness WireTriSalus Life Sciences Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma at the Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:TLSITriSalus Life Sciences Inc
10/25/20239:05AMBusiness WireTriSalus Life Sciences Announces Late Breaker and Additional Data Presentations on Liver Metastases and Pancreatic Cancer at the Society for Immunotherapy of Cancer (SITC) 2023 Annual MeetingNASDAQ:TLSITriSalus Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:TLSI